UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: ISOorifarm-20mg-Capsule-SE-IS-RA

Generated Narrative: RegulatedAuthorization ISOorifarm-20mg-Capsule-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/57968

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00057968,http://ema.europa.eu/fhir/eurdId#10488; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Capsule, soft; indication = Svåra former av akne (till exempel nodulär eller konglobat akne eller akne med risk för permanent ärrbildning) som inte kontrolleras med adekvat standardbehandling med systemiska antibakteriella läkemedel och lokalbehandling.; legalStatusOfSupply = Medicinal product subject to medical prescription; additionalMonitoringIndicator = The medicinal product is included or removed from the list of medicinal products that are subject to additional monitoring (as applicable).; classification = D10BA01

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2018-06-25

holder: Organization Orifarm Generics A/S

Cases

-TypeDate[x]
*First Authorisation2018-06-25